Literature DB >> 11786669

Epidemiological aspects of irritable bowel syndrome in Europe and North America.

S A Müller-Lissner1, S Bollani, R J Brummer, G Coremans, M Dapoigny, J K Marshall, J W Muris, A Oberndorff-Klein Wolthuis, F Pace, L Rodrigo, R Stockbrügger, M H Vatn.   

Abstract

The epidemiology of irritable bowel syndrome (IBS) in Europe and North America was analyzed from published material. The percentage of the population of Western civilisation with IBS symptoms is between 10 and 15% in most studies. The proportion of a Western population visiting a doctor for IBS symptoms is around 5%. The prevalence of IBS and the proportion of consulters do not seem to depend on age in an adult population. The female-to-male ratio of IBS in the population is close to 2. It is higher in IBS consulters in primary care and may be as high as 3 or 4 in tertiary referral centers. At least in patients from these centers, the number of physician visits and colonoscopies is considerable. Most of the consulters get a drug prescription. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11786669     DOI: 10.1159/000048862

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  27 in total

1.  Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study.

Authors:  Richard H Hunt; Surinder Dhaliwal; Gervais Tougas; Carmen Pedro; Jean-Francois Labbé; Heidi Paul; Michael Ennamorato
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

2.  Uncomfortable implications: placebo equivalence in drug management of a functional illness.

Authors:  H M Evans; A P S Hungin
Journal:  J Med Ethics       Date:  2007-11       Impact factor: 2.903

3.  Nail patella syndrome: a review of the phenotype aided by developmental biology.

Authors:  E Sweeney; A Fryer; R Mountford; A Green; I McIntosh
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

4.  Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? - A Rome III Based Prevalence Study of the Korean Medical Students.

Authors:  Hyun Joo Jung; Moo In Park; Won Moon; Seun Ja Park; Hyung Hun Kim; Eun Ji Noh; Gyu Jin Lee; Joo Hoon Kim; Dong Gyu Kim
Journal:  J Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 4.924

5.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

Review 6.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

7.  Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.

Authors:  Lisa M Lix; Marina S Yogendran; Souradet Y Shaw; Laura E Targownick; Jennifer Jones; Osama Bataineh
Journal:  BMC Health Serv Res       Date:  2010-02-01       Impact factor: 2.655

8.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

Review 9.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

Review 10.  Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?

Authors:  Margaret M Heitkemper; Lin Chang
Journal:  Gend Med       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.